SCHEMBL26847198

SCHEMBL26847198

CCc1cccc(CSc2[nH]c(=O)cc(-c3ccccc3)c2C#N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ POLB P06746 5/20 0.45
▸ TNF P01375 2/20 0.45
▸ NOD2 Q9HC29 2/20 0.45
▸ NOD1 Q9Y239 2/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD11B1 P28845 4/20 0.43
▸ ACMSD Q8TDX5 3/20 0.43
▸ ATM Q13315 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ HSD11B2 P80365 1/20 0.41
▸ SQOR Q9Y6N5 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ PLA2G1B P04054 1/20 0.40
▸ ATG4B Q9Y4P1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23852913 0.87 ACMSD (0.49) KMT2AMEN1POLBTNFNOD2
SCHEMBL20350857 0.87 ACMSD (0.56) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL26847205 0.85 KMT2A (0.43) KMT2AMEN1POLBTNFNOD2
SCHEMBL23183542 0.85 ACMSD (0.57) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL26847597 0.85 ALDH1A1 (0.56) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL20340172 0.84 ACMSD (0.61) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL20339582 0.84 KMT2A (0.64) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL26847199 0.83 ACMSD (0.48) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL24087882 0.82 ACMSD (0.55) KMT2AMEN1POLBTNFNOD2
SCHEMBL20340181 0.80 KMT2A (0.42) KMT2AMEN1POLBTNFNOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KMT2A 1353/4885MEN1 2572/4885POLB 2002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback